Search Within

Efrat Luttwak

Formats
  1. Meeting Abstract (16)
  2. Journal Article (6)
  3. Research Letter (2)
  4. Editorial (1)
  5. Review (1)
Groups
  1. GME, Medicine (26)
  2. Graduate Medical Education (26)
  3. Center for Hematologic Malignancies (24)
  4. Department of Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. Lymphoma (24)

More Groups

People
  1. Maria Palomba (20)
  2. Gilles Salles (18)
  3. Magdalena Corona De Lapuerta (13)
  4. Roni Shouval (13)
  5. Alejandro Luna De Abia (12)
  6. Gunjan Shah (12)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (14)
Publications
  1. Blood (15)
  2. Blood Cancer Journal (2)
  3. Bone Marrow Transplantation (2)
  4. Blood Advances (1)
  5. Blood Cancer Discovery (1)
  6. Current Opinion in Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (4)
  3. American Association for Cancer Research (1)
  4. Biomed Central Ltd (1)
  5. Ferrata Storti Foundation (1)
  6. Informa Healthcare (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
    Journal Article

    Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma
    Journal Article

    Luan, D.; DeWolf, S.; Fei, T.; Raj, S.; Shah, G. L.; Lareau, C. A.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Functional geriatric assessment tests predict toxicity rates in functional high risk myeloma patients treated with daratumumab, carfilzomib, lenalidomide and dexamethasone in a prospective clinical trial
    Meeting Abstract

    Shmuel, R.; Tellem, R.; Gatt, M. E.; Lavi, N.; Ganzel, C.; Luttwak, E.; Chubar, E.; Rouvio, O.; Vaxman, I.; Pasvolsky, O.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • What is the best salvage therapy for Hodgkin lymphoma?
    Review

    Luttwak, E.; Moskowitz, A. J.
    Current Opinion in Oncology (2024)

    Fulltext@MSK | Save